Andreas Rummelt - 20 May 2021 Form 4 Insider Report for ALEXION PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Douglas Barry, Attorney-in-Fact for Andreas Rummelt
Issuer symbol
N/A
Transactions as of
20 May 2021
Net transactions value
$0
Form type
4
Filing time
24 May 2021, 16:33:29 UTC
Next filing
23 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXN Common Stock, par value $.0001 per share Award $0 +1,962 +7.7% $0.000000 27,576 20 May 2021 Direct F1
transaction ALXN Common Stock, par value $.0001 per share Award $0 +533 +1.9% $0.000000 28,109 20 May 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest in their entirety on the first anniversary of the grant date.
F2 Award of Restricted Stock Units under the 2017 Incentive Plan. Shares issuable pursuant to the Restricted Stock Units vest as to 25% on a quarterly basis. These Restricted Stock Units were issued in lieu ofthe annual cash retainer that the director was entitled to receive for service as a director.